comparemela.com
Home
Live Updates
AxoSim Enters Into a Definitive Agreement to Acquire Vyant B
AxoSim Enters Into a Definitive Agreement to Acquire Vyant B
AxoSim Enters Into a Definitive Agreement to Acquire Vyant Bio's StemoniX Assets
—Combines Three Leading Human Biomimetic Organoid Platform Technologies for Neurological Drug Discovery—
Related Keywords
Minnesota ,
United States ,
New Jersey ,
Cherry Hill ,
Lowry Curley ,
Vyant Bio ,
Vyant Bio Stemoni ,
Regina Jackson ,
Barbara Lindheim ,
Axosim Nervesim ,
Andrew Lafrence ,
Axosim Inc ,
Group Inc ,
Prnewswire Axosim Inc ,
Expert Scientific Team ,
Exchange Commission ,
Vyant Bio Inc ,
Services Under Interim Distribution Agreement Effective ,
Neurological Drug Discovery ,
Axosim Gains ,
Intellectual Property ,
Along With Expert Scientific Team ,
Manufacturing Facility ,
Begin Offering ,
Brain Products ,
Chief Executive Officer ,
Chief Financial Officer ,
Sci Capital ,
Annual Report ,
Looking Statements ,
Private Securities Litigation Reform Act ,
Chief Financial ,
Region ,